- Cart - 0 item(s)
- $0.00
Your shopping cart is empty!
- Chemistry
- Bioactive Molecules
- Anti-infection
- Apoptosis
- Autophagy
- Cell Cycle/DNA Damage
- Cytoskeleton
- Epigenetics
- GPCR/G Protein
- Immunology/Inflammation
- JAK/STAT Signaling
- MAPK/ERK Pathway
- Membrane Transporter/Ion Channel
- Metabolic Enzyme/Protease
- Neuronal Signaling
- NF-κB
- PI3K/Akt/mTOR
- PROTAC
- Protein Tyrosine Kinase/RTK
- Stem Cell/Wnt
- TGF-beta/Smad
- Vitamin D Related/Nuclear Receptor
- Others
- Methylation
- Cytoskeletal Signaling
- Natural Products
- Alkaloids
- Amino acid
- Anthraquinones
- Cerebrosides
- Chalcones
- Coumarins
- Diterpenoids
- Flavonoids
- Iridoids
- Lignans
- Lipids
- Miscellaneous
- Monoterpenoids
- Other terpenes
- Phenols
- Phenylpropanoids
- Quinones
- Saccharides
- Sesquiterpenoids
- Steroids
- Tetraterpenoids
- Thiophenes
- Triterpenoids
- Xanthones
- Polyphenols
- Stibene glucosides
- Oligose
- Anthocyanins
- Miscellaneous
- Chromones
- Terpenoids
- Indoles
- Procyanidins
- Aliphatics
- Botanical Cyclopeptides
- ADCs
- Antibodies
- Multiplex IHC
- Material Science
- Others
[CAS NO. 913541-47-6] SLX-4090
| Ships within | Stock | Price | Qty | Total |
Please click "REQUEST A QUOTE" button if there is no stock, or you need other sizes or custom synthesis.
| Catalog: | HY-106011 |
| Brand: | MCE |
| CAS: | 913541-47-6 |
Overview
| MDL | MFCD28502203 |
|---|---|
| Molecular Weight | 546.54 |
| Molecular Formula | C31H25F3N2O4 |
| SMILES | O=C(N1CC2=C(C=C(NC(C3=CC=CC(OC)=C3C4=CC=C(C(F)(F)F)C=C4)=O)C=C2)CC1)OC5=CC=CC=C5 |
Summary
SLX-4090 is an orally active enterocytic-specific microsomal triglyceride transfer protein ( MTP ) inhibitor with an IC 50 of 8.0 nM. SLX-4090 can be used for the research of dyslipidemia [1] .
In Vitro
SLX-4090 inhibits apolipoprotein B (IC 50 value 9.6 nM) but not apolipoprotein A1 secretion in Caco-2 cells [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
SLX-4090 (orally, 30 mg/kg) reduces postprandial lipids by 50% with an ED 50 value 7 mg/kg in rats [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date | Phase |
|---|---|---|---|---|
| NCT00562575 | Kadmon Corporation, LLC |
Hypertriglyceridemia
|
May 2007 | Phase 2 |
| NCT00810979 | Kadmon Corporation, LLC |
Hyperlipidemia
|
January 2009 | Phase 2 |
| NCT00871936 | Kadmon Corporation, LLC |
Type 2 Diabetes
|
April 2009 | Phase 2 |
| NCT01675154 | University of Texas Southwestern Medical Center |
Type 1 Hyperlipoproteinemia
|
November 2015 | Phase 2 |
Appearance
Solid
Shipping
Room temperature in continental US; may vary elsewhere.
Storage
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Solvent & Solubility
DMSO : 100 mg/mL ( 182.97 mM ; Need ultrasonic)
Stock Solutions
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 1.8297 mL | 9.1485 mL | 18.2969 mL |
| 5 mM | 0.3659 mL | 1.8297 mL | 3.6594 mL |
| 10 mM | 0.1830 mL | 0.9148 mL | 1.8297 mL |
-
1.
-
2.
Add each solvent one by one: 10% DMSO >> 90% corn oil
Solubility: ≥ 2.5 mg/mL (4.57 mM); Clear solution
Arctom is a premier supply platform offering over 600K unique items of Building Blocks, Bioactive Molecules, Natural Products, ADC PEG Linkers, Antibodies, and other Research Chemicals for global pharmaceutical, biotech, university, and industrial customers. We accelerate your research by providing better and faster purchasing experience & services.